In 2010, Doug Olson became the second person in the world to receive CAR-T cell therapy, an experimental tactic to engineer his own immune cells to fight cancer. His doctors had tempered expectations ...
Morning Overview on MSN
A cell therapy for an aggressive childhood leukemia just won breakthrough status
Children and adults with relapsed or refractory T-cell acute lymphoblastic leukemia now have a new reason to pay attention.
Administering radiation therapy to multiple myeloma patients waiting for CAR T cells to be manufactured was found to be safe and undisruptive to CAR T therapy, according to a new study from ...
In the phase 2 ZUMA-2 study, KTE-X19 CAR-T therapy showed a lasting clinical benefit and manageable side effects in relapsed/refractory mantle cell lymphoma. Researchers sought to determine whether ...
Researchers at the University of Colorado Anschutz Medical Campus have successfully developed a supercharged iteration of CAR-T cell therapy that can enhance the effectiveness and longevity of the ...
CAR-T cell therapy for people with autoimmune diseases such as lupus is in its early stages. While the therapy presents a powerful new strategy for treatment, a recent review highlights potential ...
Real-world data shows that CAR-T therapy can lower costs for patients with pre-existing comorbidities outside of the clinical setting. Findings from a real-world study of patients with diffuse large B ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results